Luvadaxistat (NBI-1065844)
Negative Symptoms of Schizophrenia
Key Facts
Indication
Negative Symptoms of Schizophrenia
Phase
Phase II
Status
Active (INTERCEPT)
Company
About Neurocrine Biosciences
Neurocrine Biosciences has successfully transitioned from a discovery-focused entity to a fully integrated commercial leader in neuroscience. Its mission is to relieve suffering through brave science, exemplified by the blockbuster success of INGREZZA for tardive dyskinesia and a growing portfolio in movement disorders and endocrinology. The company's strategy leverages deep neurobiological expertise to advance a diversified pipeline, pursue strategic collaborations, and expand the labels of its commercial assets to drive sustainable growth.
View full company profileTherapeutic Areas
Other Negative Symptoms of Schizophrenia Drugs
| Drug | Company | Phase |
|---|---|---|
| CT-155 | Click Therapeutics | Phase 3 |